Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.


  1. Home


  2. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.


  3. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N, O’Briant K, Drescher C, Urban N. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst. 2010 J

Upcoming Events

Full Calendar


News Categories